Simard John's Form 4 filing
XBiotech Inc. (XBIT) · filed Oct 1, 2021
- Accession no.
- 0001209191-21-058475
- Filed
- Oct 1, 2021
- Trade date
- Sep 28-Oct 1, 2021
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $812.2K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simard JohnCIK 0001639078 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2021 | Common Stock | SSaleDisposed | −6,263 | $14.27 | −$89,373.01 | 4,065,703 | Direct | |
| Sep 29, 2021 | Common Stock | SSaleDisposed | −16,396 | $13.41 | −$219,870.36 | 4,049,307 | Direct | |
| Sep 30, 2021 | Common Stock | SSaleDisposed | −18,558 | $13.07 | −$242,553.06 | 4,030,749 | Direct | |
| Oct 1, 2021 | Common Stock | SSaleDisposed | −19,684 | $13.23 | −$260,419.32 | 4,011,065 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.